MKGAF
Merck KGaA
Set alert
169.25 USD +0.04 +0.02%
169.25 Day range 169.25
116.68 52-week range 175.56
- YTD
- +14.67%
- 1 year
- +29.35%
- Open
- 169.25
- Prev close
- 169.21
- Mkt cap
- 73.59B
- Vol
- 148
- Avg vol
- 646
- EPS
- 6.36
- P/E
- 26.61
More statistics
- Low
- 169.25
- High
- 169.25
- Earnings
- Nov 12, 2026
Next earnings
Nov 12, 2026
Expected Nov 12, 2026. Consensus EPS estimate 2.35.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2026 | Sep 30, 2026 | 2.35 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 2.38 | — | — | — |
| May 13, 2026 | Mar 31, 2026 | 2.25 | 2.44 | +0.19 | +8.44% |
| Mar 5, 2026 | Dec 31, 2025 | 2.29 | 2.21 | -0.08 | -3.49% |
| Nov 12, 2025 | Sep 30, 2025 | 2.59 | 2.42 | -0.17 | -6.56% |
| Aug 7, 2025 | Jun 30, 2025 | 2.52 | 1.77 | -0.75 | -29.76% |
News
- Why Is Silence Therapeutics Stock Skyrocketing Monday?
- Germany's Merck to Buy U.K. Biotech Silence Therapeutics for $1.3 Billion
- Merck KGaA (OTCMKTS:MKGAF) Shares Gap Down – Should You Sell?
- 363,066 Shares in Merck KGaA $MKGAF Purchased by Beacon Pointe Advisors LLC
- Blue Edge Capital LLC Decreases Stake in Merck KGaA $MKGAF
- Bamco Inc. NY Buys Shares of 22,000 Merck KGaA $MKGAF
- ADAR1 Capital Management LLC Invests $403,000 in Merck KGaA $MKGAF
- Ancora Advisors LLC Invests $2.69 Million in Merck KGaA $MKGAF
- Ausdal Financial Partners Inc. Takes Position in Merck KGaA $MKGAF
- AFT Forsyth & Company Inc. Invests $822,000 in Merck KGaA $MKGAF
Your note
Sign in to keep a note on MKGAF — it syncs with the Stock Master app.